AU607584B2 - A pharmaceutical composition for relieving side effects of platinum-containing drugs - Google Patents
A pharmaceutical composition for relieving side effects of platinum-containing drugs Download PDFInfo
- Publication number
- AU607584B2 AU607584B2 AU29553/89A AU2955389A AU607584B2 AU 607584 B2 AU607584 B2 AU 607584B2 AU 29553/89 A AU29553/89 A AU 29553/89A AU 2955389 A AU2955389 A AU 2955389A AU 607584 B2 AU607584 B2 AU 607584B2
- Authority
- AU
- Australia
- Prior art keywords
- ulinastatin
- cisplatinum
- administration
- platinum
- side effects
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63-26918 | 1988-02-08 | ||
JP63026918A JPH01203334A (ja) | 1988-02-08 | 1988-02-08 | 白金を含有する薬剤の副作用軽減剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2955389A AU2955389A (en) | 1989-08-10 |
AU607584B2 true AU607584B2 (en) | 1991-03-07 |
Family
ID=12206574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU29553/89A Ceased AU607584B2 (en) | 1988-02-08 | 1989-02-02 | A pharmaceutical composition for relieving side effects of platinum-containing drugs |
Country Status (8)
Country | Link |
---|---|
US (1) | US4950465A (zh) |
EP (1) | EP0327999B1 (zh) |
JP (1) | JPH01203334A (zh) |
AT (1) | ATE76754T1 (zh) |
AU (1) | AU607584B2 (zh) |
CA (1) | CA1329541C (zh) |
DE (1) | DE68901656T2 (zh) |
GR (1) | GR3005276T3 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5466678A (en) * | 1992-09-04 | 1995-11-14 | Fuji Kagaku Kogyo Kabushiki Kaisha | Co-administration of S-adenosyl-L-methionine to reduce the nephrotoxicity of cisplatin therapy |
CN1160123C (zh) * | 2003-05-26 | 2004-08-04 | 广东天普生化医药股份有限公司 | 乌司他丁用于治疗严重急性呼吸综合征的用途及其药物组合物 |
MX2019014354A (es) * | 2017-05-30 | 2020-07-28 | Zavante Therapeutics Inc | Metodos para identificar nuevos regimenes de dosificacion. |
BR112022017718A2 (pt) | 2020-03-05 | 2022-11-16 | Diamedica Usa Inc | Polipeptídeos de ulinastatina |
WO2024111404A1 (ja) * | 2022-11-21 | 2024-05-30 | 協和発酵バイオ株式会社 | 抗がん剤により誘発される急性腎障害の予防又は治療剤 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6028928A (ja) * | 1983-07-27 | 1985-02-14 | Meiji Seika Kaisha Ltd | 制癌剤の副作用軽減剤 |
IT1200467B (it) * | 1985-05-06 | 1989-01-18 | Boehringer Biochemia Srl | Formulazione farmaceutica |
JPS62106021A (ja) * | 1985-11-01 | 1987-05-16 | Eisai Co Ltd | エラスタ−ゼの利用方法 |
-
1988
- 1988-02-08 JP JP63026918A patent/JPH01203334A/ja active Granted
-
1989
- 1989-02-02 AU AU29553/89A patent/AU607584B2/en not_active Ceased
- 1989-02-03 EP EP89101939A patent/EP0327999B1/en not_active Expired - Lifetime
- 1989-02-03 DE DE8989101939T patent/DE68901656T2/de not_active Expired - Fee Related
- 1989-02-03 AT AT89101939T patent/ATE76754T1/de not_active IP Right Cessation
- 1989-02-07 US US07/307,686 patent/US4950465A/en not_active Expired - Fee Related
- 1989-02-07 CA CA000590264A patent/CA1329541C/en not_active Expired - Fee Related
-
1992
- 1992-07-29 GR GR920401606T patent/GR3005276T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
GR3005276T3 (zh) | 1993-05-24 |
AU2955389A (en) | 1989-08-10 |
JPH0560813B2 (zh) | 1993-09-03 |
ATE76754T1 (de) | 1992-06-15 |
EP0327999A1 (en) | 1989-08-16 |
DE68901656D1 (de) | 1992-07-09 |
DE68901656T2 (de) | 1993-02-11 |
JPH01203334A (ja) | 1989-08-16 |
EP0327999B1 (en) | 1992-06-03 |
US4950465A (en) | 1990-08-21 |
CA1329541C (en) | 1994-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bonkowsky et al. | Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin | |
US4485095A (en) | Pronase used for the treatment of diseases of the liver and kidneys in humans and animals | |
US4745099A (en) | Pharmaceutical composition for the treatment of the anemia of malignant tumors | |
US4137307A (en) | Process for preparing haptoglobin aqueous solution using strong anion exchanger | |
US4748157A (en) | Composition for gastrointestinal ulcers | |
AU607584B2 (en) | A pharmaceutical composition for relieving side effects of platinum-containing drugs | |
US4061735A (en) | Haptoglobin in aqueous solution and process for preparing the same | |
EP0124018B1 (en) | Pharmaceutical preparation containing purified fibronectin | |
Ter Borg et al. | Use of sodium hydroxide solution to clear partially occluded vascular access ports | |
JPS6237615B2 (zh) | ||
Tihen | Central pontine myelinolysis and Rosenthal fibers of the brainstem: association with emaciation and prolonged intravenous hyperalimentation | |
EP0278416B1 (en) | Use of human blood coagulation factor xiii for the treatment of ulcerative colitis | |
Hiraoka et al. | Systemic Capillary Leak Syndrome Associated with Multiple Myeloma of IgG κType | |
Sinclair et al. | Intravenous Iron in Hypochromic Anaemia Associated with Rheumatoid Arthritis | |
US4479937A (en) | Process of treating inflammation with human urinary thiol protease inhibitor | |
AU725441B2 (en) | An agent for preventing and/or treating multiple organ failure | |
Umeki et al. | Urinastatin (Kunitz-type proteinase inhibitor) reducing cisplatin nephrotoxicity | |
Hassan | Treatment of meprobamate overdose with repeated oral doses of activated charcoal | |
Kirschke et al. | Coagulation and fibrinolysis in children with acute lymphoblastic leukaemia treated according to the COALL-05-92-protocol | |
Jaffe et al. | Inhibition of gastrin activity by incubation with antibodies to the C-terminal tetrapeptide of gastrin | |
Thomson et al. | Acute myelogenous leukemia treated with daunomycin associated with nephrotic syndrome | |
Keipert et al. | Metabolism, Distribution, and Excretion of HbXL: A Nondissociating Interdimerically Crosslinked Hemoglobin with Exceptional Oxygen Offloading Capability | |
Kopple et al. | Effects of amino acid infusion and renal failure on the uptake and release of amino acids by the dog kidney | |
Folb | Intravenous infusions | |
Fukuoka et al. | A phase I study of chronic daily dosing of oral etoposide in combination with cisplatin for patients with advanced cancer |